In MDS cells with primary SF3B1 mutation, inhibiting IRAK4 with CA-4948 decreased NF-kB activation and production of inflammatory cytokines, along with an increase in myeloid colony, myeloid differentiation, and reduction in leukemic growth in a xenografted mice model [59]. The gene discussed is IRAK4; the disease is myelodysplastic syndrome.